Kingsway Biotechnology announced on March 13, 2024 that it has granted a total of 444,598 shares of restricted shares to employees and consultants under the 2021 Restricted Share Award Scheme. The reward scheme is designed to encourage employees and consultants to contribute to the long-term growth and overall performance of the company. Restrictive Share Bonus Shares awarded to employees will be allocated on the basis of the achievement of specific performance targets, while those awarded by consultants do not meet performance targets. The limited share bonus shares will be distributed in bulk from 2025 to 2027 and will not provide financial assistance to the grantor to purchase the shares. The restricted share bonus shares granted in this grant represent approximately 0.0209% of the Company's issued...Show More

Kingsway Biotechnology announced on March 13, 2024 that it has granted a total of 444,598 shares of restricted shares to employees and consultants under the 2021 Restricted Share Award Scheme. The reward scheme is designed to encourage employees and consultants to contribute to the long-term growth and overall performance of the company. Restrictive Share Bonus Shares awarded to employees will be allocated on the basis of the achievement of specific performance targets, while those awarded by consultants do not meet performance targets. The limited share bonus shares will be distributed in bulk from 2025 to 2027 and will not provide financial assistance to the grantor to purchase the shares. The restricted share bonus shares granted in this grant represent approximately 0.0209% of the Company's issued share capital and will be held in trust until the end of each assignment. The Board of Directors believes that this will help align the interests of employees and consultants with those of the company and its shareholders and motivate them to contribute to the future development and growth of the company.